Normal Diffusing Capacity in Patients With PiZ α1-Antitrypsin Deficiency, Severe Airflow Obstruction, and Significant Radiographic Emphysema
- 1 September 2000
- Vol. 118 (3), 867-871
- https://doi.org/10.1378/chest.118.3.867
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Survival and FEV1Decline in Individuals with Severe Deficiency of α1-AntitrypsinAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study groupEuropean Respiratory Journal, 1997
- Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha 1-antitrypsin deficiency.American Journal of Respiratory and Critical Care Medicine, 1995
- Long-term follow-up of a cohort of children with alpha-1-antitrypsin deficiencyThe Journal of Pediatrics, 1990
- Emphysema vs Asthma with Antitrypsin DeficiencyChest, 1989
- Comparison of Single Breath Carbon Monoxide Diffusing Capacity and Pressure-Volume Curves in Detecting EmphysemaAmerican Review of Respiratory Disease, 1989
- Clinical Features and History of the Destructive Lung Disease Associated with Alpha-1-Antitrypsin Deficiency of Adults with Pulmonary SymptomsAmerican Review of Respiratory Disease, 1988
- SMOKING, LUNG FUNCTION, AND α1-ANTITRYPSIN DEFICIENCYThe Lancet, 1985
- Alpha-1-Antitrypsin DeficiencyClinics in Chest Medicine, 1983
- Natural History and Life Expectancy in Severe Alpha1‐Antitrypsin Deficiency, Pi ZActa Medica Scandinavica, 1978